28
total announcements
CAMLINFINE.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,760 Cr
P/E (Forward)
11.2
EPS (TTM)
₹-3.00
52W Low
₹88.16
52W High
₹204.57
Dividend Yield
0.00%
Beta
0.68
Price / Book
1.7
Debt / Equity
72.0
Revenue (TTM)
₹1,835 Cr
Gross Margin
43.58%
Operating Margin
-0.29%
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the retirement of Mr. Pradip Kanakia as Independent Director of the Company, effective October 18, 2026, after completing his 5-year term.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding Proceedings of Postal Ballot. The company has submitted the Exchange a copy of Scrutinizer's report along with voting results for the appointment of Mr. Atul Pradhan as a Non-Executive Independent Director.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has allotted 1200 equity shares to employees under the CFSL Employees Stock Option Scheme, 2018, increasing the issued and paid-up equity share capital to Rs. 19,20,97,813.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance/rejection of securities received for dematerialisation during the quarter ended September 30, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the publication of a notice of postal ballot and remote e-voting process in newspapers.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding Notice of Postal Ballot for appointment of Mr. Atul Pradhan as a Non-Executive Independent Director of the Company.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding the appointment of Mr. Atul Pradhan as an Additional Non-Executive Independent Director of the company, effective September 11, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the transcript of the conference call on the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has published un-audited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 219 crores, with a basic EPS of Rs. 0.31 and a diluted EPS of Rs. 0.31.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the link of recording of the conference call on the un-audited financial results for the quarter ended June 30, 2026. The audio recording is available on the company's website.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has released its investor presentation for Q1FY27, highlighting a 28% increase in revenue to Rs. 5,199 mn, with EBITDA margin at 3.4% and PAT at Rs. 10 mn. The company expects growth momentum to continue despite higher raw material prices and logistics costs.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a standalone profit/loss of ₹123.12 crore and a consolidated profit/loss of ₹-336.22 crore.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited held its 33rd Annual General Meeting on August 11, 2026, through video conferencing. The meeting was conducted in compliance with the circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The shareholders approved all the items of business contained in the AGM Notice, and the voting results were made available on the company's website.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about a scheduled conference call with investors and analysts to discuss the Un-audited financial results for the quarter ended June 30, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about the dispatch of notice of its 33rd Annual General Meeting through video conferencing.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about letters sent to Shareholders regarding the Annual Report 2025-26 and the 33rd Annual General Meeting (AGM) scheduled for August 11, 2026.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026, to consider and adopt audited financial statements for FY 2025-26, re-appointment of directors, and other business.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has informed the Exchange about a copy of newspaper publication related to the 33rd Annual General Meeting of the company.
Camlin Fine Sciences Limited
Camlin Fine Sciences Limited has completed the simplified cash tender offer for the remaining shares of Vinpai, acquiring 95.41% of the share capital and 91.46% of the theoretical voting rights. The company will not request a squeeze-out procedure for Vinpai shares from the Euronext Growth Paris market.